Literatur
Nach Informationen von MSD
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
red US-Zulassung für Pembrolizumab. hautnah dermatologie 30, 58 (2014). https://doi.org/10.1007/s15012-014-1945-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15012-014-1945-7